Home | Welcome to Contract Pharma   
Last Updated Saturday, March 28 2015

Print

Search Results for 'Phase II'

Search For:
Refine by Dates:
From: To:
Past 7 Days        Past 30 Days
Refine By Content:

Contract Service Directory Companies

View All Companies »


Contract Service Directory Categories

View All Categories »


Search Results:

By Gil Roth
Published November 11, 2013
Chronic pain treatment Z160 cancelled, company to focus on Z944 Read More »
By Gil Roth
Published October 11, 2013
Trial showed no PML cases Read More »
By Gil Roth
Published October 9, 2013
IPT trials in patients with wet AMD and VMT Read More »
Published February 27, 2012
Following initial safety (Phase I) testing, a drug is tested for efficacy, typically in blind, randomized trials, in which a control group receives a placebo. Phase II testing may last from several months to two years. Phase II trials involve 100-300… Read More »
Published May 25, 2011
Sixth milestone resulting from 2005 CNS pact Read More »
Published November 23, 2010
Abbott achieved positive results from a Phase II dose-ranging study of atrasentan, a highly selective endothelin A receptor antagonist in development to help slow chronic kidney disease (CKD) progression in patients with type 2 diabetic kidney disease. Read More »
Published August 7, 2007
Althea Technologies, Inc. has been selected by GeoVax Labs, Inc., an Atlanta-based biotechnology company, to manufacture its HIV-1 DNA (AIDS) vaccine for GeoVax’s Phase II trials, expected to begin in early 2008. GeoVax AIDS vaccines ar… Read More »
Published May 10, 2006
Kendle will acquire the Phase II-IV Clinical Services business of Charles River Laboratories International, Inc. for approximately $215 million in cash. The move will strengthen Kendle's position in the clinical development industry, adding therapeut… Read More »
High Potency Rebuttal
By Karen Ginsbury; Destin A. LeBlanc, PCI Pharmaceutical Consuting; Cleaning Validation Technologies
Published January 22, 2014
Clarifying the uncertainty remaining in the quest to define “certain” products Read More »
By Gil Roth
Published January 14, 2014
Tests CNP analog against achondoplasia in children Read More »


Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On